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1. Introduction 
Metformin HCl (MET) chemically N; N dimethylimidodicarbonimidic diamide hydrochloride is used as 
antidiabitic drug from the biguanide class used in the management of type 2 diabetes. Major action of metformin lay in 
increasing glucose transport across the cell membrane in skeletal muscle. [1-4] 
 
Figure 1: Chemical structure of Metformin HCl 
Glimepiride is 1-{(p-[2-(3-ethyl-4-methyl- 2-oxo-3- pyrroline-1-carboxamide) ethyl] phenyl) sulfonyl}-3- (trans-
4-methylcyclohexyl) urea, is 3
rd
 generation sulfonylurea derivative used for the treatment of type II diabetes mellitus. [5-7] 
 
Figure 2: Chemical structure of Glimepiride 
Abstract 
Simple, precise, economical, fast and reliable two UV methods have been 
developed for the simultaneous estimation of Metformin HCl and Glimepiride in bulk 
and pharmaceutical dosage form. Method A is Absorbance maxima method, which is 
based on measurement of absorption at maximum wavelength of 236 nm and 228 nm 
for Metformin HCl and Glimepiride respectively. Method B is area under curve 
(AUC), in the wavelength range of 217-247 nm for Metformin HCl and 213-239 nm 
for Glimepiride. Linearity for detector response was observed in the concentration 
range of 5- 25μg/ml for Metformin HCl and 5-25 μg/ml for Glimepiride. The 
accuracy of the methods was assessed by recovery studies and was found to be 
100.23 % and 99.67 % for Metformin HCl and Glimepiride respectively. The 
developed method was validated with respect to linearity, accuracy (recovery), 
precision and specificity. The results were validated statistically as per ICH Q2 R1 
guideline and were found to be satisfactory. The proposed methods were successfully 
applied for the determination of for Metformin HCl and Glimepiride in commercial 
pharmaceutical dosage form. 
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A survey of pertinent literature revealed that in estimation of individual as well as combination of Metformin HCl 
and Glimepiride. Simultaneous determinations of Metformin HCl and Glimepiride dosage form were also reported like 
HPLC [8, 9], RP-HPLC [10-13], LC [14] and UV-Spectroscopy [15-19]. Therefore an attempt was made to develop a new 
rapid and sensitive UV Spectrophotometric method and to validate as per ICH-guidelines. A comprehensive literature 
research reveals the lack of a Spectrophotometric analytical method for simultaneous estimation of Metformin HCl and 
Glimepiride in pharmaceutical formulations. A successful attempt was made to develop accurate, precise and simple 
method of analysis for estimation of both the drugs in combined dosage form. 
 
2. Materials and Methods 
2.1 Apparatus and instrumentation 
A shimadzu 1800 UV/VIS double beam spectrophotometer with 1cm matched quartz cells was used for all spectral 
measurements. Single Pan Electronic balance (CONTECH, CA 223, India) was used for weighing purpose. Sonication of 
the solutions was carried out using an Ultrasonic Cleaning Bath (Spectra lab UCB 40, India).Calibrated volumetric 
glassware (Borosil®) was used for the validation study. 
2.2 Materials 
Reference standard of Metformin HCl and Glimepiride API were supplied as gift sample by Lupin Laboratory 
Park Aurangabd. The commercial formulation Gluconorm-G 4 with label claim 500 mg Metformin HCl and 4 mg 
Glimepiride per tablet were purchased from local market Mangalwedha, Dist:-Solapur. 
2.3 Method development 
2.3.1 Preparation of standard stock solution 
Stock solution was prepared by diluting 10 mg of each drug in sufficient quantity of methanol in separate 
volumetric flask and volume was made up to 100 ml to get the concentrations of 100 μg/ml for each drug. Dilutions from 
stock solution were prepared in the range of 5-25 μg/ml for Metformin HCl and 5-25 μg/ml for Glimepiride. Methanol was 
used as a blank solution. 
2.3.2 Method A: Absorption Maxima Method 
For the selection of analytical wavelength, standard solution of Metformin HCl and Glimepiride were scanned in 
the spectrum mode from 400 nm to 200 nm separately. From the spectra of drug λmax of Metformin HCl, 236 nm [Fig.3], 
and λmax of Glimepiride, 228 nm [Fig.4], were selected for the analysis. Aliquots of standard stock solution were made and 
calibration curve was plotted. [20-22] 
 
Figure 3: It shows λmax of Metformin HCl  
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Figure 4: It shows λmax of Glimepiride 
 
2.3.3 Simultaneous estimation of Metformin HCl and Glimepiride: 
The wavelength maxima of Metformin HCl and Glimepiride were determined and found to be 236 nm (λ1) and 
228 nm (λ2) respectively where there was no interference among the drugs. The overlain spectrum is shown in Fig. 5.  
 
 
Figure 5: Isobestic point of Metformin HCl and Glimepiride 
 
2.3.4 Method B: Area under Curve Method 
From the spectra of drug obtained after scanning of standard solution of Metformin HCl and Glimepiride 
separately, area under the curve in the range of 217-247 nm and 213-239 nm was selected for the analysis. The calibration 
curve was prepared in the concentration range of 5-25 μg/ml for Metformin HCl and 5-25 μg/ml for Glimepiride at their 
respective AUC range. Both drugs followed the Beer-Lambert’s law in the above mentioned concentration range. The 
calibration curves were plotted as absorbance against concentration of HCl and Glimepiride. The coefficient of correlation 
(r), slope and intercept values of this method are given in Table 2.  
 
Area calculation: (α+β) = 𝐴𝑑λ
λ1
λ2
 
Where, α is area of portion bounded by curve data and a straight line connecting the start and end  point, β is  the  
area  of  portion  bounded  by  a  straight  line  connecting  the  start  and  end point on curve data and horizontal axis λ1 
and λ2  are wavelength range start and end point of curve region. [23-25] 
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2.3.5 Application of the proposed methods for the determination of Metformin HCl and Glimepiride in tablet dosage 
form 
For the estimation of drugs in the tablet formulation, 20 tablets were weighed and weight equivalent to 500 mg of 
Metformin HCl and 4 mg of Glimepiride was transferred to 50 ml volumetric flask and ultrasonicated for 20 minutes and 
volume was made up to the mark with methanol. The solution was then filtered through a Whatmann filter paper (No.42). 
The filtrate was appropriately diluted further.  
Table 1: Table shows Results of Analysis of Tablet Formulation 
Method 
 
Drug 
Label Claim 
mg 
Sample Solution 
Concentration (µg/ml) 
Amount found 
(%)*± 
% 
Recovery 
%RSD 
A Metformin HCl 500 mg 20 100.18 ±1.24 100.69 
0.6394 
B Metformin HCl 500 mg 20 99.47±0.98 99.07 
A Glimepiride 4 mg 20 101.29±1.47 101.54 
0.6481 
B Glimepiride 4 mg 20 99.69±1.76 101.96 
                                                    *n=3, % RSD = % Relative Standard Deviation. 
In Method-A, the concentration of Metformin HCl and Glimepiride was determined by measuring the absorbance 
of the sample at 236 nm and 228 nm respectively in zero order spectrum modes. By using the calibration curve, the 
concentration of the sample solution was determined. 
 
Figure 6: It shows AUC of Metformin HCl 
 
Figure 7: It shows AUC of Glimepiride 
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In Method-B, the concentration of Metformin HCl and Glimepiride was determined by measuring area under curve 
in the range of 217-247 nm and 213-239 nm. By using the calibration curve, the concentration of the sample solution was 
determined. 
 
3. Validation of the Developed Methods: [26-31] 
The methods were validated with respect to accuracy, linearity, precision and selectivity. 
3.1 Accuracy: - Accuracy of an analysis was determined by systemic error involved. Accuracy may often be expressed as 
% Recovery by the assay of known, added amount of analyte. It is measure of the exactness of the analytical method. 
Recovery studies carried out for both the methods by spiking standard drug in the powdered formulations 80%, 100%, 
120% amount of each dosage content as per ICH guidelines. 
3.2 Linearity: - The linearity of measurement was evaluated by analyzing different concentration of the standard solution 
of Metformin HCl and Glimepiride. Result should be expressed in terms of correlation co-efficient. 
 
 
 
Figure 8: Calibration curve for Metformin HCl at 236 nm 
 
Figure 9: Calibration curve for Glimepiride at 228 nm 
 
3.3 Precision: - The reproducibility of the proposed method was determined by performing tablet assay at different time 
intervals (morning, afternoon and evening) on same day (Intra-day assay precision) and on three different days (Inter-day 
precision). Result of intra-day and inter-day precision is expressed in % RSD. 
3.4 Sensitivity: - The limit of detection (LOD) and limit of quantification (LOQ) were calculated by using the equations 
LOD = 3xσ/ S and LOQ = 10xσ/S, where σ is the standard deviation of intercept, S is the slope. The LOD and LOQ were 
found to be 0.7480 μg/ml and 2.4491μg/ml respectively of Metformin HCl and 0.7904 μg/ml and 2.3718 μg/ml of 
Glimepiride. 
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Table 2: Optical Characteristics and Precision 
Sr. No. Parameter Metformin HCl Glimepiride 
1 λ range 200-400 nm 200-400nm 
2 Regression Equation (y= mx+c) Y=0.201x+0.056 Y=0.211x+0.028 
3 Measured wavelength 236 nm 228 nm 
4 Linearity range 5-25µg/ml 5-25µg/ml 
5 Slope 0.201 0.211 
6 Intercept 0.056 0.028 
7 Correlation coefficient (R
2
) 0.998 0.999 
8 Limit of Detection (LOD) µg/ml 0.7480 0.7904 
9 Limit of Quantitation (LOQ) µg/ml 2.4491 2.3718 
 
Table 3: Results of drug content and analytical recovery of Metformin HCl and Glimepiride 
Excess drug added 
to the analyte (%) 
Drug % Recovery % RSD 
Method A Method B Method A Method B 
80  
Metformin HCl 
100.23 101.58 0.5962 0.5874 
100 98.28 100.92 0.4780 0.7149 
120 99.10 99.69 0.4982 0.5241 
 
80  
Glimepiride 
99.67 100.93 0.6589 0.4120 
100 98.84 101.21 0.6317 0.5715 
120 100.29 101.28 0.5470 0.6583 
 
Table 4: Results of Intra-day and Inter-day Precision 
Method Drug Intra-day Precision Inter-day Precision 
     SD      %RSD      SD      %RSD 
A Metformin HCl 0.785 0.428 0.681 0.381 
B 0.774 0.398 0.589 0.265 
 
A Glimepiride 0.248 0.845 0.187 0.107 
B 0.198 0.745 0.142 0.099 
 
4. Results and Discussion 
The methods discussed in the present work provide a convenient and accurate way for analysis of Metformin HCl 
and Glimepiride in its bulk and pharmaceutical dosage form. Absorbance maxima of Metformin HCl at 236 nm and 
Glimepiride at 228 nm were selected for the analysis. Linearity for detector response was observed in the concentration 
range of 5-25 μg/ml for Metformin HCl and 5-25 μg/ml for Glimepiride. Percent amount found for Metformin HCl and 
Glimepiride in tablet analysis was found in the range of 100.18 %, 99.47 and 101.29, 99.69 % respectively [Table 1]. 
Standard deviation and coefficient of variance for three determinations of tablet formulation, was found to be less than ± 
2.0 indicating the precision of the methods. Accuracy of proposed methods was ascertained by recovery studies and the 
results are expressed as % recovery. % recovery for Metformin HCl and Glimepiride was found in the range of 100.23 % 
and 99.67 % values of standard deviation and coefficient of variation was satisfactorily low indicating the accuracy of all 
the methods. % RSD for Intraday assay precision for Metformin HCl was found to be 0.785 and 0.774 for Method A and B, 
and for Glimepiride, 0.248 and 0.198 for Method A and B. Interday assay precision for Metformin HCl was found to be 
0.681 and 0.589 for Method A and B and for Glimepiride 0.187 and 0.142 for Method A and B. The LOD and LOQ were 
found to be 0.7480 μg/ml and 2.4491μg/ml respectively of Metformin HCl and 0.7904 μg/ml and 2.3718 μg/ml of 
Glimepiride. Based on the results obtained, it is found that the proposed methods are accurate, precise, reproducible & 
economical and can be employed for routine quality control of Metformin HCl and Glimepiride in bulk drug and its 
pharmaceutical dosage form. 
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5. Conclusion 
UV spectrophotometric methods for Metformin HCl and Glimepiride were developed separately in bulk and tablet 
dosage form by, Absorbance maxima method and Area under curve method. Further, UV Spectrophotometric methods for 
the simultaneous estimation of Metformin HCl and Glimepiride were in bulk and combined dosage form. The methods 
were validated as per ICH guidelines. The standard deviation and % RSD calculated for these methods are <2, indicating 
high degree of precision of the methods. The results of the recovery studies showed the high degree of accuracy of these 
methods. In conclusion, the developed methods are accurate, precise and selective and can be employed successfully for the 
estimation of Metformin HCl and Glimepiride in bulk and pharmaceutical dosage form. 
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